Sign in
4

Changes in Ownership

REGENERON PHARMACEUTICALS, INC. Filed Acc 0001968202-24-000090

Director sold 100 shares at an average $962.53 ($96,253)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

RYAN ARTHUR F · Director

Table I: Non-derivative

9 lines
Date Transaction Shares Price Value Owned after D/I
2024-04-01 Sale : show line 1 in the form 10b5-1 −2 $957.78 $1,916 18,280 D
2024-04-01 Sale : show line 2 in the form 10b5-1 −2 $958.86 $1,918 18,278 D
2024-04-01 Sale : show line 3 in the form 10b5-1 −9 $959.47 $8,635 18,269 D
2024-04-01 Sale : show line 4 in the form 10b5-1 −15 $960.53 $14,408 18,254 D
2024-04-01 Sale : show line 5 in the form 10b5-1 −14 $961.59 $13,462 18,240 D
2024-04-01 Sale : show line 6 in the form 10b5-1 −9 $962.42 $8,662 18,231 D
2024-04-01 Sale : show line 7 in the form 10b5-1 −20 $963.60 $19,272 18,211 D
2024-04-01 Sale : show line 8 in the form 10b5-1 −16 $964.45 $15,431 18,195 D
2024-04-01 Sale : show line 9 in the form 10b5-1 −13 $965.35 $12,550 18,182 D
Open-market sales · 100 sh · avg $962.53 · $96,253
Loading xslF345X05/edgardoc.xml…